Molecular Determinants of Substrate/Inhibitor Binding to the Human and Rabbit Renal Organic Cation Transporters hOCT2 and rbOCT2
- 1 April 2005
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 67 (4) , 1067-1077
- https://doi.org/10.1124/mol.104.004713
Abstract
Organic cation transporters are important for the elimination of many drugs and toxins from the body. In the present study, substrate-transporter interactions were investigated in Chinese hamster ovary cells stably transfected with either the human or rabbit orthologs of the principal organic cation transporter in the kidney, OCT2. IC50 values, ranging from 0.04 μM to >3 mM, for inhibition of [14C]tetraethylammonium transport were determined for more than 30 structurally diverse compounds. Although the two OCT orthologs displayed similar IC50 values for some of these compounds, the majority varied by as much as 20-fold. Marked differences in substrate affinity were also noted when comparing hOCT2 to the closely related homolog hOCT1. These data suggest the molecular determinants of substrate binding differ markedly among both homologous and orthologous OCT transporters. The software package Cerius2 (Accelrys, San Diego, CA) was used to generate a descriptor-based, two-dimensional, quantitative structure-activity relationship (QSAR) to produce a model relating the affinity of hOCT2 to particular physicochemical features of substrate/inhibitor molecules (r2 = 0.81). Comparative molecular field analysis (Tripos, St. Louis, MO) was used to generate three-dimensional QSARs describing the structural basis of substrate binding to hOCT2 and rbOCT2 (q2 = 0.60 and 0.53, respectively, and each with r2 = 0.97). The quality of the models was assessed by their ability to successfully predict the inhibition of a set of test compounds. The current models enabled prediction of OCT2 affinity and may prove useful in the prediction of unwanted drug interactions at the level of the renal secretory process.Keywords
This publication has 26 references indexed in Scilit:
- Predicting undesirable drug interactions with promiscuous proteins in silicoDrug Discovery Today, 2004
- Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3)The Journal of Pharmacology and Experimental Therapeutics, 2004
- Influence of Molecular Structure on Substrate Binding to the Human Organic Cation Transporter, hOCT1Molecular Pharmacology, 2003
- The Human Organic Cation Transporter (hOCT2) Recognizes the Degree of Substrate IonizationJournal of Biological Chemistry, 2002
- Interactions of n-Tetraalkylammonium Compounds and Biguanides with a Human Renal Organic Cation Transporter (hOCT2)Pharmaceutical Research, 2002
- Prediction of pharmacokinetic properties using experimental approaches during early drug discoveryCurrent Opinion in Chemical Biology, 2001
- NBD-TMA: a novel fluorescent substrate of the peritubular organic cation transporter of renal proximal tubulesPflügers Archiv - European Journal of Physiology, 2000
- Selectivity of the Polyspecific Cation Transporter rOCT1 Is Changed by Mutation of Aspartate 475 to GlutamateMolecular Pharmacology, 1999
- Human Neurons Express the Polyspecific Cation Transporter hOCT2, Which Translocates Monoamine Neurotransmitters, Amantadine, and MemantineMolecular Pharmacology, 1998
- Review Physiological pharmacokinetic modellingXenobiotica, 1990